| For: | Xia HHX, Fan XG, Talley NJ. Clarithromycin resistance in Helicobacter pylori and its clinical relevance. World J Gastroenterol 1999; 5(3): 263-266 [PMID: 11819443 DOI: 10.3748/wjg.v5.i3.263] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v5/i3/263.htm |
| Number | Citing Articles |
| 1 |
Abhigan Babu Shrestha, Pashupati Pokharel, Unnat Hamal Sapkota, Sajina Shrestha, Shueb A. Mohamed, Surakshya Khanal, Saroj Kumar Jha, Aroop Mohanty, Bijaya Kumar Padhi, Ankush Asija, Yub Raj Sedhai, Rishikesh Rijal, Karan Singh, Vijay Kumar Chattu, Alfonso J. Rodriguez-Morales, Joshuan J. Barboza, Ranjit Sah. Drug Resistance Patterns of Commonly Used Antibiotics for the Treatment of Helicobacter pylori Infection among South Asian Countries: A Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease 2023; 8(3) doi: 10.3390/tropicalmed8030172
|
| 2 |
SP THYAGARAJAN, PALLAB RAY, BIMAL KUMAR DAS, ARCHANA AYYAGARI, ALEEM AHMED KHAN, S DHARMALINGAM, USHA ANAND RAO, P RAJASAMBANDAM, B RAMATHILAGAM, DEEPAK BHASIN, MP SHARMA, SR NAIK, CM HABIBULLAH. Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. Journal of Gastroenterology and Hepatology 2003; 18(12) doi: 10.1046/j.1440-1746.2003.03174.x
|
| 3 |
Majid Eslami, Bahman Yousefi, Parviz Kokhaei, Ali Jazayeri Moghadas, Bizhan Sadighi Moghadam, Vahid Arabkari, Zohreh Niazi. Are probiotics useful for therapy of Helicobacter pylori diseases?. Comparative Immunology, Microbiology and Infectious Diseases 2019; 64 doi: 10.1016/j.cimid.2019.02.010
|
| 4 |
Taghi Naserpour Farivar, Reza Najafipour, Pouran Johari. Prevalence of clarithromycin‐resistant Helicobacter pylori in patients with chronic tonsillitis by allele‐specific scorpion real‐time polymerase chain reaction assay. The Laryngoscope 2013; 123(6) doi: 10.1002/lary.23777
|
| 5 |
Harry Hua-Xiang Xia, Benjamin Chun Yu Wong, Nicholas J Talley, Shiu Kum Lam. Helicobacter pylori infection - current treatment practice. Expert Opinion on Pharmacotherapy 2001; 2(2) doi: 10.1517/14656566.2.2.253
|
| 6 |
Mohammadreza Seyyedmajidi, Kianoosh Falaknazi, Dariush Mirsattari, Homayoun Zojaji, Mohammad Roshani, Farhad Lahmi, Peyman Gooran Orimi, Maryam Hadizadeh, Mohammadreza Zali. Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: A randomised clinical trial. Arab Journal of Gastroenterology 2011; 12(3) doi: 10.1016/j.ajg.2011.07.004
|
| 7 |
COMPARATIVE EFFICACY OF VONOPRAZAN AND PROTON PUMP INHIBITORS IN HELICOBACTER PYLORI ERADICATION BASED ON CLARITHROMYCIN SUSCEPTIBILITY: A SYSTEMATIC REVIEW AND META-ANALYSIS. Asian Journal of Pharmaceutical and Clinical Research 2025; doi: 10.22159/ajpcr.2025v18i9.55714
|
| 8 |
Nicholas J Talley, Shiu Kum Lam, Benjamin Chun Yu Wong, Harry Hua-Xiang Xia. Alternative and rescue treatment regimens for Helicobacter pylori eradication. Expert Opinion on Pharmacotherapy 2002; 3(9) doi: 10.1517/14656566.3.9.1301
|
| 9 |
Zsolt Tulassay, Manfred Stolte, Maria Sjölund, Lars Engstrand, Eugeniusz Butruk, Peter Malfertheiner, Petr Dite, Konstantin Tchernev, Benjamin C.Y. Wong, Mattis Gottlow, Stefan Eklund, Michael Wrangstadh, Péter Nagy. Effect of esomeprazole triple therapy on eradication rates of Helicobacter pylori, gastric ulcer healing and prevention of relapse in gastric ulcer patients. European Journal of Gastroenterology & Hepatology 2008; 20(6) doi: 10.1097/MEG.0b013e3282f427ac
|
| 10 |
Jun-Hyung Cho. Tegoprazan–Amoxicillin Dual Therapy for Clarithromycin-Resistant Helicobacter pylori: A Feasibility Pilot Study. Microorganisms 2025; 13(10) doi: 10.3390/microorganisms13102408
|
| 11 |
Javed Yakoob, Xuegong Fan, Guoling Hu, Li Liu, Zheng Zhang. Antibiotic susceptibility of Helicobacter pylori in the Chinese population. Journal of Gastroenterology and Hepatology 2001; 16(9) doi: 10.1046/j.1440-1746.2001.02553.x
|
| 12 |
Ugur Yilmaz, Murat Korkmaz, Fusun Kamber Can, Muge Demirbilek, Gurden Gur, Sedat Boyacioglu, Selim Aydemir. <italic>Helicobacter pylori</italic> infection in hemodialysis patients: Susceptibility to amoxicillin and clarithromycin. World Journal of Gastroenterology 2005; 11(6): 842-845 doi: 10.3748/wjg.v11.i6.842
|
| 13 |
Hee-Seon Park, Charith U.B. Wijerathne, Hye-Yun Jeong, Chang-Seob Seo, Hyekyung Ha, Hyo-Jung Kwun. Gastroprotective effects of Hwanglyeonhaedok-tang against Helicobacter pylori-induced gastric cell injury. Journal of Ethnopharmacology 2018; 216 doi: 10.1016/j.jep.2018.01.025
|
| 14 |
Josip Bago, Anita Galović, Željka Belošié Halle, A. Bilić, M. Bevanda, Petra Bago. Comparison of the efficacy of 250 mg and 500 mg clarithromycin used with lansoprazole and amoxicillin in eradication regimens forHelicobacter pylori infection. Wiener Klinische Wochenschrift 2004; 116(14) doi: 10.1007/BF03040946
|
| 15 |
Yuan Yuan, Bao-Sen Zhou, Xuan Zhang, Hai-Long Shi, Peng Guan, Hai-Qiang Guo. Prospective cohort study of comprehensive prevention to gastric cancer. World Journal of Gastroenterology 2003; 9(3): 432-436 doi: 10.3748/wjg.v9.i3.432
|
| 16 |
Ebru Demiray‐Gürbüz, Özlem Yılmaz, Asalia Z Olivares, Can Gönen, Sülen Sarıoğlu, Müjde Soytürk, Sait Tümer, Oğuz Altungöz, İlkay Şimşek, Guillermo I Perez Perez. Rapid identification of Helicobacter pylori and assessment of clarithromycin susceptibility from clinical specimens using FISH. The Journal of Pathology: Clinical Research 2017; 3(1) doi: 10.1002/cjp2.57
|
| 17 |
David Yates Graham, Theodore Rokkas.
Overcoming the effects of increasing antimicrobial resistance on
Helicobacter pylori
therapy
. Expert Review of Gastroenterology & Hepatology 2024; 18(11) doi: 10.1080/17474124.2024.2435520
|
| 18 |
Marouf Alhalabi, Rasha Almokdad. Efficacy of a 2-week therapy with levofloxacin concomitant versus a levofloxacin sequential regimen for Helicobacter pylori infection in the Syrian population: a study protocol for randomized controlled trial. Trials 2024; 25(1) doi: 10.1186/s13063-024-07906-3
|
| 19 |
S Dharmalingam, UA Rao, G Jayaraman, SP Thyagarajan. RELATIONSHIP OF PLASMID PROFILE WITH THE ANTIBIOTIC SENSITIVITY PATTERN OF HELICOBACTER PYLORI ISOLATES FROM PEPTIC ULCER DISEASE PATIENTS IN CHENNAI. Indian Journal of Medical Microbiology 2003; 21(4) doi: 10.1016/S0255-0857(21)03009-7
|
| 20 |
Yang Bai, Ya-Li Zhang, Jian-Feng Jin, Ji-De Wang, Zhao-Shan Zhang, Dian-Yuan Zhou. Recombinant <italic>Helicobacter pylori</italic> catalase. World Journal of Gastroenterology 2003; 9(5): 1119-1122 doi: 10.3748/wjg.v9.i5.1119
|
| 21 |
Zheng Jiang, Ai-Long Huang, Xiao-Hong Tao, Pi-Long Wang. Construction and characterization of bivalent vaccine candidate expressing HspA and <italic>M</italic><sub>r</sub>18000 OMP from <italic>Helicobacter pylori</italic>. World Journal of Gastroenterology 2003; 9(8): 1756-1761 doi: 10.3748/wjg.v9.i8.1756
|